# Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section

> **NCT02044549** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 300 (actual)

## Conditions studied

- Postpartum Hemorrhage
- Blood Loss

## Interventions

- **DRUG:** carbetocin
- **DRUG:** Syntometrine

## Key facts

- **NCT ID:** NCT02044549
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2021-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02044549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02044549, "Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02044549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*